China Covid update: 180,000 people in Guangdong receive Covid-19 vaccine

Some 180,000 people with higher risks of coronavirus infection in south China's Guangdong Province have been given Covid-19 vaccine candidates as of Tuesday, the provincial government said.

No serious side effects have been reported among the vaccine receivers, said the information office of the local government of Guangdong at a press briefing on Wednesday, Xinhua news agency reported.

The vaccine candidates, still undergoing clinical trials, were made by the China National Biotec Group and Beijing-based Sinovac, said the office.

Guangdong has started a Covid-19 vaccination campaign among groups of people with higher risks of infection. They include medical workers, customs officers, primary-level epidemic prevention workers, overseas returnees, and people working in cross-border cold-chain logistics and isolation centres.

--IANS

int/


(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel